Industrial Purity Specifications For 2-Methyl-4-(2-Methylbenzamide)Benzoic Acid
- Target Assay: Pharmaceutical grade requires ≥98.0% purity by HPLC for Tolvaptan synthesis.
- Key Impurities: Strict control of regioisomers and unreacted starting materials is critical for GMP compliance.
- Supply Chain: Bulk procurement strategies significantly reduce unit costs compared to research-scale packaging.
In the pharmaceutical manufacturing sector, the quality of key intermediates dictates the safety and efficacy of the final active pharmaceutical ingredient (API). 2-Methyl-4-(2-Methylbenzamide)Benzoic Acid, identified by CAS Number 317374-08-6, serves as a critical building block in the synthesis of Tolvaptan, a vasopressin receptor antagonist. For process chemists and procurement managers, understanding the industrial purity specifications is not merely a regulatory requirement but a necessity for optimizing reaction yields and minimizing downstream purification costs.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control standards to ensure that every batch meets the demanding specifications required for GMP production. This technical overview details the chemical properties, analytical verification methods, and commercial considerations necessary for sourcing this intermediate at an industrial scale.
Required Assay Purity and Impurity Thresholds for GMP Use
The molecular formula C16H15NO3 corresponds to a molecular weight of approximately 269.3 g/mol. While research-grade samples often appear in milligram quantities with varying purity levels, industrial applications demand consistency. The standard industrial purity for this intermediate in pharmaceutical synthesis typically exceeds 98.0%, with specific impurity profiles tightly controlled.
Impurities often arise from the synthesis route, particularly regioisomers where the acylation occurs at incorrect positions on the benzene ring. Additionally, residual starting materials such as 2-methylbenzoic acid derivatives must be minimized. High levels of these impurities can interfere with subsequent coupling reactions, leading to reduced overall yields in the final API production. Therefore, specifications often include limits for individual unknown impurities (typically ≤0.10%) and total impurities (typically ≤1.0%).
Physical appearance is also a quality indicator. The substance should present as a white to off-white powder. Deviations in color can indicate oxidation or thermal degradation during the manufacturing process. Storage conditions recommend sealing in dry environments at room temperature to prevent hydrolysis of the amide bond, which possesses a predicted pKa of approximately 4.04.
Analytical Methods for Quality Verification (HPLC, NMR, MS)
Reliable quality assurance relies on robust analytical methods. High-Performance Liquid Chromatography (HPLC) is the primary technique for quantifying assay purity. Standard conditions often utilize a UV detector set at a wavelength of 254 nm. Columns such as ODS-A C18 phases are employed with mobile phases consisting of buffered aqueous solutions and organic modifiers like acetonitrile. This setup ensures precise separation of the target molecule from closely related structural analogs.
Structural confirmation is achieved through Nuclear Magnetic Resonance (NMR) spectroscopy. Proton NMR spectra in DMSO-d6 typically display characteristic singlets for the methyl groups around δ2.39 and δ2.53 ppm, alongside aromatic multiplets. The amide proton signal usually appears as a singlet near δ10.50 ppm, while the carboxylic acid proton is observed further downfield. Mass Spectrometry (MS) provides further validation of the molecular ion peak, confirming the integrity of the molecular weight.
When evaluating potential suppliers, buyers should request comprehensive data packages. For instance, when sourcing high-purity 2-Methyl-4-[(2-methylbenzoyl)amino]benzoic acid, buyers should verify that the provided spectra match the expected chemical shifts and fragmentation patterns. This due diligence prevents costly production delays caused by substandard raw materials.
COA Requirements for Pharmaceutical Intermediate Compliance
A Certificate of Analysis (COA) is the foundational document for chemical procurement. For 2-Methyl-4-(2-Methylbenzamide)Benzoic Acid, a compliant COA must include more than just a pass/fail status. It should detail the specific test methods used, the batch number, and the manufacturing date. Critical parameters include assay content, loss on drying, residue on ignition, and heavy metal limits.
Safety data is equally important. The material carries GHS07 warning symbols with hazard statements H302, H315, H319, and H335. Consequently, the COA should reference appropriate precautionary statements (P261, P305+P351+P338) to ensure safe handling during industrial processing. NINGBO INNO PHARMCHEM CO.,LTD. ensures that all documentation aligns with international safety and quality regulations, facilitating smoother customs clearance and warehouse intake.
Commercial Considerations and Bulk Procurement
Pricing dynamics for chemical intermediates vary significantly based on volume. Market intelligence indicates that research-scale packaging (e.g., 5g to 10g) commands a premium bulk price per unit weight, often exceeding hundreds of dollars per kilogram equivalent. In contrast, industrial procurement in kilogram or metric ton quantities offers substantial cost efficiencies.
The table below outlines typical specification tiers and their commercial implications:
| Grade Specification | Typical Purity (HPLC) | Primary Application | Procurement Strategy |
|---|---|---|---|
| Research Grade | 95.0% - 97.0% | Lab Scale Screening | Small Pack (g/mg) |
| Industrial Grade | 98.0% - 99.0% | Pilot Plant / API Synthesis | Bulk (kg) |
| GMP Grade | ≥99.0% | Commercial API Production | Contract Manufacturing |
Optimizing the manufacturing process is key to maintaining competitive pricing while ensuring quality. Lab-scale synthesis routes involving oxalyl chloride and aluminum chloride have demonstrated yields around 65.8% with recrystallization. Scaling this process requires careful thermal management and solvent recovery systems to maintain profitability. Suppliers capable of optimizing these reaction conditions can offer more stable supply chains and better pricing structures.
Furthermore, lead times and supply ability are critical factors. While some market sources list limited stock levels, established manufacturers maintain robust inventory management to support continuous production lines. A reliable COA accompanied by consistent availability ensures that pharmaceutical manufacturers can meet their own production schedules without interruption.
Conclusion
Securing a reliable supply of 2-Methyl-4-(2-Methylbenzamide)Benzoic Acid requires a deep understanding of technical specifications and commercial dynamics. From verifying industrial purity through advanced analytical methods to negotiating favorable bulk price agreements, every step impacts the final quality of the Tolvaptan API. Partnering with an experienced entity like NINGBO INNO PHARMCHEM CO.,LTD. provides access to high-quality intermediates backed by comprehensive technical support and regulatory compliance.